{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:59:27Z","timestamp":1789916367541,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T00:00:00Z","timestamp":1311120000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s12640-011-9259-6","type":"journal-article","created":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T16:46:00Z","timestamp":1311093960000},"page":"185-194","source":"Crossref","is-referenced-by-count":23,"title":["Mitochondrial Dysfunction Precedes Other Sub-Cellular Abnormalities in an In Vitro Model Linked with Cell Death in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"21","author":[{"given":"C. J.","family":"Yong-Kee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sidorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hanif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Nash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,7,20]]},"reference":[{"key":"9259_CR1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1471-4159.2004.02485.x","volume":"90","author":"HC Ardley","year":"2004","unstructured":"Ardley HC, Scott GB, Rose SA, Tan NG, Robinson PA (2004) UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson\u2019s disease. J Neurochem 90:379\u2013391","journal-title":"J Neurochem"},{"key":"9259_CR2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"9259_CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/BF01276421","volume":"103","author":"H Braak","year":"1996","unstructured":"Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J (1996) Pattern of brain destruction in Parkinson\u2019s and Alzheimer\u2019s diseases. J Neural Transm 103:455\u2013490","journal-title":"J Neural Transm"},{"key":"9259_CR4","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.addr.2008.03.020","volume":"60","author":"DW Busija","year":"2008","unstructured":"Busija DW, Gaspar T, Domoki F, Katakam PV, Bari F (2008) Mitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning. Adv Drug Deliv Rev 60:1471\u20131477","journal-title":"Adv Drug Deliv Rev"},{"key":"9259_CR5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.neuro.2008.03.004","volume":"29","author":"HS Cho","year":"2008","unstructured":"Cho HS, Kim S, Lee SY, Park JA, Kim SJ, Chun HS (2008) Protective effect of the green tea component, l-theanine on environmental toxins-induced neuronal cell death. Neurotoxicology 29:656\u2013662","journal-title":"Neurotoxicology"},{"key":"9259_CR6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.nbd.2009.05.023","volume":"35","author":"Y Chu","year":"2009","unstructured":"Chu Y, Dodiya H, Aebischer P, Olanow CW, Kordower JH (2009) Alterations in lysosomal and proteasomal markers in Parkinson\u2019s disease: relationship to alpha-synuclein inclusions. Neurobiol Dis 35:385\u2013398","journal-title":"Neurobiol Dis"},{"key":"9259_CR7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.brainres.2007.07.083","volume":"1176","author":"WG Chung","year":"2007","unstructured":"Chung WG, Miranda CL, Maier CS (2007) Epigallocatechin gallate (EGCG) potentiates the cytotoxicity of rotenone in neuroblastoma SH-SY5Y cells. Brain Res 1176:133\u2013142","journal-title":"Brain Res"},{"key":"9259_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1385\/NMM:3:1:1","volume":"3","author":"MR Cookson","year":"2003","unstructured":"Cookson MR (2003) Parkin\u2019s substrates and the pathways leading to neuronal damage. Neuromol Med 3:1\u201313","journal-title":"Neuromol Med"},{"key":"9259_CR9","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","volume":"305","author":"AM Cuervo","year":"2004","unstructured":"Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292\u20131295","journal-title":"Science"},{"key":"9259_CR10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2010.01.053","volume":"472","author":"S Dadakhujaev","year":"2010","unstructured":"Dadakhujaev S, Noh HS, Jung EJ, Cha JY, Baek SM, Ha JH, Kim DR (2010) Autophagy protects the rotenone-induced cell death in alpha-synuclein overexpressing SH-SY5Y cells. Neurosci Lett 472:47\u201352","journal-title":"Neurosci Lett"},{"key":"9259_CR11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1212\/01.wnl.0000260963.08711.08","volume":"68","author":"A Di Fonzo","year":"2007","unstructured":"Di Fonzo A et al (2007) ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 68:1557\u20131562","journal-title":"Neurology"},{"key":"9259_CR12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn1927","volume":"7","author":"JM Gidday","year":"2006","unstructured":"Gidday JM (2006) Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7:437\u2013448","journal-title":"Nat Rev Neurosci"},{"key":"9259_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2010.10.014","volume":"68","author":"J Hardy","year":"2010","unstructured":"Hardy J (2010) Genetic analysis of pathways to Parkinson disease. Neuron 68:201\u2013206","journal-title":"Neuron"},{"key":"9259_CR14","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1471-4159.2009.06403.x","volume":"111","author":"T Hatano","year":"2009","unstructured":"Hatano T, Kubo S, Sato S, Hattori N (2009) Pathogenesis of familial Parkinson\u2019s disease: new insights based on monogenic forms of Parkinson\u2019s disease. J Neurochem 111:1075\u20131093","journal-title":"J Neurochem"},{"key":"9259_CR15","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/0955-0674(92)90135-Y","volume":"4","author":"M Hochstrasser","year":"1992","unstructured":"Hochstrasser M (1992) Ubiquitin and intracellular protein degradation. Curr Opin Cell Biol 4:1024\u20131031","journal-title":"Curr Opin Cell Biol"},{"key":"9259_CR16","first-page":"390","volume":"50","author":"O Hornykiewicz","year":"1972","unstructured":"Hornykiewicz O (1972) Dopamine and extrapyramidal motor function and dysfunction. Res Publ Assoc Res Nerv Ment Dis 50:390\u2013415","journal-title":"Res Publ Assoc Res Nerv Ment Dis"},{"key":"9259_CR17","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1093\/hmg\/ddq288","volume":"19","author":"I Irrcher","year":"2010","unstructured":"Irrcher I et al (2010) Loss of the Parkinson\u2019s disease-linked gene DJ-1 perturbs mitochondrial dynamics. Hum Mol Genet 19:3734\u20133746","journal-title":"Hum Mol Genet"},{"key":"9259_CR18","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0404.1993.tb00013.x","volume":"146","author":"P Jenner","year":"1993","unstructured":"Jenner P (1993) Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson\u2019s disease. Acta Neurol Scand Suppl 146:6\u201313","journal-title":"Acta Neurol Scand Suppl"},{"key":"9259_CR19","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/hmg\/ddh180","volume":"13","author":"H Jiang","year":"2004","unstructured":"Jiang H, Ren Y, Zhao J, Feng J (2004) Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis. Hum Mol Genet 13:1745\u20131754","journal-title":"Hum Mol Genet"},{"key":"9259_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0306-4522(00)00077-4","volume":"97","author":"S Kanda","year":"2000","unstructured":"Kanda S, Bishop JF, Eglitis MA, Yang Y, Mouradian MM (2000) Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation. Neuroscience 97:279\u2013284","journal-title":"Neuroscience"},{"key":"9259_CR21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1515\/bc.2010.058","volume":"391","author":"N Kettern","year":"2010","unstructured":"Kettern N, Dreiseidler M, Tawo R, Hohfeld J (2010) Chaperone-assisted degradation: multiple paths to destruction. Biol Chem 391:481\u2013489","journal-title":"Biol Chem"},{"key":"9259_CR22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumine H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605\u2013608","journal-title":"Nature"},{"key":"9259_CR23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.parkreldis.2008.05.005","volume":"15","author":"A Koch","year":"2009","unstructured":"Koch A, Lehmann-Horn K, Dachsel JC, Gasser T, Kahle PJ, Lucking CB (2009) Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells. Parkinsonism Relat Disord 15:220\u2013225","journal-title":"Parkinsonism Relat Disord"},{"key":"9259_CR24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jb\/mvp139","volume":"146","author":"H Kubota","year":"2009","unstructured":"Kubota H (2009) Quality control against misfolded proteins in the cytosol: a network for cell survival. J Biochem 146:609\u2013616","journal-title":"J Biochem"},{"key":"9259_CR25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0306-4522(03)00441-X","volume":"121","author":"A Lannuzel","year":"2003","unstructured":"Lannuzel A, Michel PP, Hoglinger GU, Champy P, Jousset A, Medja F, Lombes A, Darios F, Gleye C, Laurens A, Hocquemiller R, Hirsch EC, Ruberg M (2003) The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism. Neuroscience 121:287\u2013296","journal-title":"Neuroscience"},{"key":"9259_CR26","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.wnl.0000265228.66664.f4","volume":"68","author":"AJ Lees","year":"2007","unstructured":"Lees AJ, Singleton AB (2007) Clinical heterogeneity of ATP13A2 linked disease (Kufor-Rakeb) justifies a PARK designation. Neurology 68:1553\u20131554","journal-title":"Neurology"},{"key":"9259_CR27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/BF00308959","volume":"79","author":"PN Leigh","year":"1989","unstructured":"Leigh PN, Probst A, Dale GE, Power DP, Brion JP, Dodson A, Anderton BH (1989) New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies. Acta Neuropathol 79:61\u201372","journal-title":"Acta Neuropathol"},{"key":"9259_CR28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0079-6123(10)84004-X","volume":"184","author":"I Magen","year":"2010","unstructured":"Magen I, Chesselet MF (2010) Genetic mouse models of Parkinson\u2019s disease the state of the art. Prog Brain Res 184:53\u201387","journal-title":"Prog Brain Res"},{"key":"9259_CR29","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1371\/journal.pbio.0020327","volume":"2","author":"C Martinat","year":"2004","unstructured":"Martinat C, Shendelman S, Jonason A, Leete T, Beal MF, Yang L, Floss T, Abeliovich A (2004) Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES-derived cell model of primary Parkinsonism. PLoS Biol 2:e327","journal-title":"PLoS Biol"},{"key":"9259_CR30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/ana.410370306","volume":"37","author":"AM Murray","year":"1995","unstructured":"Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN (1995) Damage to dopamine systems differs between Parkinson\u2019s disease and Alzheimer\u2019s disease with parkinsonism. Ann Neurol 37:300\u2013312","journal-title":"Ann Neurol"},{"key":"9259_CR31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1385\/MN:31:1-3:081","volume":"31","author":"M Naoi","year":"2005","unstructured":"Naoi M, Maruyama W, Shamoto-Nagai M, Yi H, Akao Y, Tanaka M (2005) Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol Neurobiol 31:81\u201393","journal-title":"Mol Neurobiol"},{"key":"9259_CR32","doi-asserted-by":"crossref","first-page":"8014","DOI":"10.1021\/bi900619j","volume":"48","author":"T Nonaka","year":"2009","unstructured":"Nonaka T, Hasegawa M (2009) A cellular model to monitor proteasome dysfunction by alpha-synuclein. Biochemistry 48:8014\u20138022","journal-title":"Biochemistry"},{"key":"9259_CR33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4161\/auto.5172","volume":"4","author":"JA Olzmann","year":"2008","unstructured":"Olzmann JA, Chin LS (2008) Parkin-mediated K63-linked polyubiquitination: a signal for targeting misfolded proteins to the aggresome-autophagy pathway. Autophagy 4:85\u201387","journal-title":"Autophagy"},{"key":"9259_CR34","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","volume":"26","author":"WD Parker Jr","year":"1989","unstructured":"Parker WD Jr, Boyson SJ, Parks JK (1989) Abnormalities of the electron transport chain in idiopathic Parkinson\u2019s disease. Ann Neurol 26:719\u2013723","journal-title":"Ann Neurol"},{"key":"9259_CR35","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.neulet.2008.02.021","volume":"435","author":"JJ Qian","year":"2008","unstructured":"Qian JJ, Cheng YB, Yang YP, Mao CJ, Qin ZH, Li K, Liu CF (2008) Differential effects of overexpression of wild-type and mutant human alpha-synuclein on MPP+-induced neurotoxicity in PC12 cells. Neurosci Lett 435:142\u2013146","journal-title":"Neurosci Lett"},{"key":"9259_CR36","doi-asserted-by":"crossref","first-page":"12681","DOI":"10.1074\/jbc.C800036200","volume":"283","author":"S Radke","year":"2008","unstructured":"Radke S, Chander H, Schafer P, Meiss G, Kruger R, Schulz JB, Germain D (2008) Mitochondrial protein quality control by the proteasome involves ubiquitination and the protease Omi. J Biol Chem 283:12681\u201312685","journal-title":"J Biol Chem"},{"key":"9259_CR37","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez A, Heimbach A, Grundemann J, Stiller B, Hampshire D, Cid LP, Goebel I, Mubaidin AF, Wriekat AL, Roeper J, Al-Din A, Hillmer AM, Karsak M, Liss B, Woods CG, Behrens MI, Kubisch C (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184\u20131191","journal-title":"Nat Genet"},{"key":"9259_CR38","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.embor.embor764","volume":"4","author":"E Sakata","year":"2003","unstructured":"Sakata E, Yamaguchi Y, Kurimoto E, Kikuchi J, Yokoyama S, Yamada S, Kawahara H, Yokosawa H, Hattori N, Mizuno Y, Tanaka K, Kato K (2003) Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep 4:301\u2013306","journal-title":"EMBO Rep"},{"key":"9259_CR39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10571-010-9609-6","volume":"31","author":"K Sapkota","year":"2011","unstructured":"Sapkota K, Kim S, Park SE, Kim SJ (2011) Detoxified extract of Rhus verniciflua stokes inhibits rotenone-induced apoptosis in human dopaminergic cells, SH-SY5Y. Cell Mol Neurobiol 31:213\u2013223","journal-title":"Cell Mol Neurobiol"},{"key":"9259_CR40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jnr.10777","volume":"74","author":"M Shamoto-Nagai","year":"2003","unstructured":"Shamoto-Nagai M, Maruyama W, Kato Y, Isobe K, Tanaka M, Naoi M, Osawa T (2003) An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells. J Neurosci Res 74:589\u2013597","journal-title":"J Neurosci Res"},{"key":"9259_CR41","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1371\/journal.pbio.0020362","volume":"2","author":"S Shendelman","year":"2004","unstructured":"Shendelman S, Jonason A, Martinat C, Leete T, Abeliovich A (2004) DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. PLoS Biol 2:e362","journal-title":"PLoS Biol"},{"key":"9259_CR42","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2006.04333.x","volume":"100","author":"TB Sherer","year":"2007","unstructured":"Sherer TB, Richardson JR, Testa CM, Seo BB, Panov AV, Yagi T, Matsuno-Yagi A, Miller GW, Greenamyre JT (2007) Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson\u2019s disease. J Neurochem 100:1469\u20131479","journal-title":"J Neurochem"},{"key":"9259_CR43","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1523\/JNEUROSCI.21-24-09549.2001","volume":"21","author":"L Stefanis","year":"2001","unstructured":"Stefanis L, Larsen KE, Rideout HJ, Sulzer D, Greene LA (2001) Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death. J Neurosci 21:9549\u20139560","journal-title":"J Neurosci"},{"key":"9259_CR44","doi-asserted-by":"crossref","first-page":"20699","DOI":"10.1074\/jbc.M313579200","volume":"279","author":"PG Sullivan","year":"2004","unstructured":"Sullivan PG, Dragicevic NB, Deng JH, Bai Y, Dimayuga E, Ding Q, Chen Q, Bruce-Keller AJ, Keller JN (2004) Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem 279:20699\u201320707","journal-title":"J Biol Chem"},{"key":"9259_CR45","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/hmg\/10.9.919","volume":"10","author":"Y Tanaka","year":"2001","unstructured":"Tanaka Y, Engelender S, Igarashi S, Rao RK, Wanner T, Tanzi RE, Sawa A, LD V, Dawson TM, Ross CA (2001) Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum Mol Genet 10:919\u2013926","journal-title":"Hum Mol Genet"},{"key":"9259_CR46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbadis.2008.10.016","volume":"1792","author":"V Todde","year":"2009","unstructured":"Todde V, Veenhuis M, van der Klei IJ (2009) Autophagy: principles and significance in health and disease. Biochim Biophys Acta 1792:3\u201313","journal-title":"Biochim Biophys Acta"},{"key":"9259_CR47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pneurobio.2004.05.002","volume":"73","author":"O von Bohlen und Halbach","year":"2004","unstructured":"von Bohlen und Halbach O, Schober A, Krieglstein K (2004) Genes, proteins, and neurotoxins involved in Parkinson\u2019s disease. Prog Neurobiol 73:151\u2013177","journal-title":"Prog Neurobiol"},{"key":"9259_CR48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10863-009-9253-3","volume":"41","author":"AJ Whitworth","year":"2009","unstructured":"Whitworth AJ, Pallanck LJ (2009) The PINK1\/Parkin pathway: a mitochondrial quality control system? J Bioenerg Biomembr 41:499\u2013503","journal-title":"J Bioenerg Biomembr"},{"key":"9259_CR49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.brainres.2009.07.067","volume":"1292","author":"F Wu","year":"2009","unstructured":"Wu F, Poon WS, Lu G, Wang A, Meng H, Feng L, Li Z, Liu S (2009) Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells. Brain Res 1292:173\u2013179","journal-title":"Brain Res"},{"key":"9259_CR50","first-page":"1086","volume":"123","author":"HR Xie","year":"2010","unstructured":"Xie HR, Hu LS, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chin Med J 123:1086\u20131092","journal-title":"Chin Med J"},{"key":"9259_CR51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10072-010-0340-3","volume":"32","author":"H Xie","year":"2011","unstructured":"Xie H, Chang M, Hu X, Wang D, Tian M, Li G, Jiang H, Wang Y, Dong Z, Zhang Y, Hu L (2011) Proteomics analysis of MPP(+)-induced apoptosis in SH-SY5Y cells. Neurol Sci 32:221\u2013228","journal-title":"Neurol Sci"},{"key":"9259_CR52","first-page":"7","volume":"19","author":"CJ Yong-Kee","year":"2011","unstructured":"Yong-Kee CJ, Salomonczyk D, Nash JE (2011) Development and validation of a screening assay for the evaluation of putative neuroprotective agents in the treatment of Parkinson\u2019s disease. Neurotox Res 19:7","journal-title":"Neurotox Res"},{"key":"9259_CR53","doi-asserted-by":"crossref","first-page":"14500","DOI":"10.1523\/JNEUROSCI.5141-08.2008","volume":"28","author":"J Yun","year":"2008","unstructured":"Yun J, Cao JH, Dodson MW, Clark IE, Kapahi P, Chowdhury RB, Guo M (2008) Loss-of-function analysis suggests that Omi\/HtrA2 is not an essential component of the PINK1\/PARKIN pathway in vivo. J Neurosci 28:14500\u201314510","journal-title":"J Neurosci"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-011-9259-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-011-9259-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-011-9259-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T21:39:42Z","timestamp":1712612382000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-011-9259-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,20]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9259"],"URL":"https:\/\/doi.org\/10.1007\/s12640-011-9259-6","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,20]]}}}